Surrogate scores of advanced fibrosis in NAFLD/NASH do not predict mortality in patients with medium-to-high cardiovascular risk | American Journal of Physiology-Gastrointestinal and Liver Physiology
Triglycerides and low HDL cholesterol predict coronary heart disease risk in patients with stable angina | Scientific Reports
Causal Inference for Genetically Determined Levels of High-Density Lipoprotein Cholesterol and Risk of Infectious Disease | Arteriosclerosis, Thrombosis, and Vascular Biology
HDL cholesterol concentrations and risk of atherosclerotic cardiovascular disease – Insights from randomized clinical trials and human genetics - ScienceDirect
LDL-C, NON-HDL-C and APO-B for cardiovascular risk assessment: Looking for the ideal marker - ScienceDirect
Prognostic implications of surrogate markers of atherosclerosis in low to intermediate risk patients with Type 2 Diabetes – topic of research paper in Health sciences. Download scholarly article PDF and read for
Lifestyle Therapy Targeting Hyperinsulinemia Normalizes Hyperglycemia and Surrogate Markers of Insulin Resistance in a Large, Free-Living Population - AJPM Focus
Association of triglycerides to high-density lipoprotein cholesterol ratio with incident cardiovascular disease but not end-stage kidney disease among patients with biopsy-proven diabetic nephropathy | Hypertension Research
The use of surrogate end points in cardiovascular disease and diabetes - The British Journal of Cardiology
Surrogate markers for coronary heart disease (CHD) shown divided... | Download Table
Small Dense Low-Density Lipoprotein-Cholesterol Concentrations Predict Risk for Coronary Heart Disease | Arteriosclerosis, Thrombosis, and Vascular Biology
e Overall approach to lipid-lowering therapy for prevention of... | Download Scientific Diagram
Nutrients | Free Full-Text | Crosstalk of Magnesium and Serum Lipids in Dyslipidemia and Associated Disorders: A Systematic Review
HDL and cardiovascular disease - The Lancet
Log-linear association of per-unit change in LDL-C and CVD risk. Data... | Download Scientific Diagram
![PDF] Can HbA1c act as a surrogate marker for cardiovascular risk | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/c6b976f01c0c593e19179b81912a33d94615a0f6/4-Table1-1.png "PDF] Can HbA1c act as a surrogate marker for cardiovascular risk | Semantic Scholar")
PDF] Can HbA1c act as a surrogate marker for cardiovascular risk | Semantic Scholar
Metabolites | Free Full-Text | A New Look at Novel Cardiovascular Risk Biomarkers: The Role of Atherogenic Lipoproteins and Innovative Antidiabetic Therapies
Remnants, LDL, and the Quantification of Lipoprotein-Associated Risk in Atherosclerotic Cardiovascular Disease | Current Atherosclerosis Reports
There is a U shaped association between non high density lipoprotein cholesterol with overall and cardiovascular mortality in chronic kidney disease stage 3–5 | Scientific Reports
Molecules | Free Full-Text | Sex-Related Differences of the Effect of Lipoproteins and Apolipoproteins on 10-Year Cardiovascular Disease Risk; Insights from the ATTICA Study (2002–2012)
Immunologic profile and surrogate markers of subclinical... | Download Scientific Diagram
![Therapeutics Initiative | [92] The limitations and potential hazards of using surrogate markers](https://www.ti.ubc.ca/wordpress/wp-content/uploads/2015/10/92.jpg "Therapeutics Initiative | [92] The limitations and potential hazards of using surrogate markers")
Therapeutics Initiative | [92] The limitations and potential hazards of using surrogate markers
Is high-density lipoprotein a modifiable treatment target or just a biomarker for cardiovascular disease? - Martin B Whyte, 2019
![PDF] Triglyceride-to-HDL cholesterol ratio in the dyslipidemic classification of type 2 diabetes. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/dda10f9b019499dad45db8d2a3f438d0dbd40cf6/2-Figure1-1.png "PDF] Triglyceride-to-HDL cholesterol ratio in the dyslipidemic classification of type 2 diabetes. | Semantic Scholar")
PDF] Triglyceride-to-HDL cholesterol ratio in the dyslipidemic classification of type 2 diabetes. | Semantic Scholar
